Persistent response to combination therapy of pemigatinib and chemotherapy in a child of combined hepatocellular-cholangiocarcinoma with FGFR2 fusion

Abstract Combined hepatocellular-cholangiocarcinoma (cHCC-CCA), an extremely rare and underinvestigated subtype of primary liver cancer in children, generally has a poor prognosis and greater aggressiveness. Histological diagnosis of cHCC-CCA is difficult because of its diverse components, including...

Повний опис

Бібліографічні деталі

Автори:	Guo-qian He, Qing Li, Xiao-yu Jing, Jian Li, Ju Gao, Xia Guo
Формат:	Artigo
Мова:	Inglês
Опубліковано:	BMC 2024-12-01
Серія:	Molecular Cancer
Предмети:	Hepatoblastoma, Children, combined hepatocellular-cholangiocarcinoma Hepatocellular carcinoma Cholangiocarcinoma FGFR2
Онлайн доступ:	https://doi.org/10.1186/s12943-024-02190-w
Теги:	Додати тег Немає тегів, Будьте першим, хто поставить тег для цього запису!